statistiche ricercatore

Continente	#
NA - Nord America	563
EU - Europa	445
AS - Asia	294
SA - Sud America	31
AF - Africa	13
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.350

Nazione	#
US - Stati Uniti d'America	549
SG - Singapore	108
RU - Federazione Russa	102
CN - Cina	85
IT - Italia	75
FI - Finlandia	45
VN - Vietnam	40
DE - Germania	38
SE - Svezia	34
UA - Ucraina	32
BR - Brasile	23
FR - Francia	23
PL - Polonia	23
IE - Irlanda	17
GB - Regno Unito	13
BG - Bulgaria	11
TR - Turchia	11
IN - India	10
BD - Bangladesh	9
RO - Romania	9
CA - Canada	8
JP - Giappone	8
PT - Portogallo	8
ZA - Sudafrica	6
HK - Hong Kong	5
ES - Italia	3
ID - Indonesia	3
JM - Giamaica	3
MA - Marocco	3
NL - Olanda	3
AU - Australia	2
CH - Svizzera	2
CL - Cile	2
EC - Ecuador	2
ET - Etiopia	2
GR - Grecia	2
IQ - Iraq	2
MY - Malesia	2
PK - Pakistan	2
PY - Paraguay	2
A2 - ???statistics.table.value.countryCode.A2???	1
AR - Argentina	1
AZ - Azerbaigian	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
GT - Guatemala	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
KR - Corea	1
LK - Sri Lanka	1
LT - Lituania	1
MD - Moldavia	1
MX - Messico	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PE - Perù	1
PH - Filippine	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TG - Togo	1
TW - Taiwan	1
Totale	1.350

Nome	#
Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An In Vitro Electron Paramagnetic Resonance Study	204
Physical interactions between marine phytoplankton and PET plastics in seawater.	187
Electron paramagnetic resonance applications: from drug discovery to marine biology studies	179
Metallodendrimers as a promising tool in the biomedical field: An overview	158
Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR	143
Elaborated study of Cu (II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents	139
DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes	136
Insight into the antitumor activity of carbosilane Cu( )–metallodendrimers through their interaction with biological membrane models	131
Synthesis and biological and physico-chemical characterization of glycodendrimers and oligopeptides for the treatment of systemic lupus erythematosus	105
Totale	1.382

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	27	0	0	0	0	0	0	0	0	0	0	0	27
2021/2022	110	13	3	9	12	0	4	5	7	5	10	5	37
2022/2023	186	19	22	8	33	13	32	0	8	32	4	7	8
2023/2024	73	12	4	4	12	4	19	1	4	0	8	2	3
2024/2025	274	14	6	31	13	20	23	51	8	23	25	47	13
2025/2026	456	36	34	32	60	37	50	38	22	47	59	26	15
Totale													1.382